Metraipolis › archive › dc_af2912b95176
FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG) — Europe PMC PMID:40940827
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40940827
- DOI
- 10.3390/cancers17172730
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T10:27:18.111Z
- SHA-256 of the archived text
91e8572b94885d4ef69c2c60e2dad7f2e45e5762035d36607df58e479c8ff950- Stable URL of this page
https://metraipolis.com/documento/dc_af2912b95176
How to cite
FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG) — Europe PMC PMID:40940827 — Europe PMC (en), https://europepmc.org/article/MED/40940827 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_af2912b95176 (Metraipolis archive dc_af2912b95176, sha256 91e8572b94885d4ef69c2c60e2dad7f2e45e5762035d36607df58e479c8ff950)
BibTeX
@misc{dcaf2912b95176,
title = {FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG) — Europe PMC PMID:40940827},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40940827},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_af2912b95176; sha256 91e8572b94885d4ef69c2c60e2dad7f2e45e5762035d36607df58e479c8ff950},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940827. Agents can read the archived copy with the MCP tool read_document.